The Fund Grade · free · no account needed
What grade does VMGRX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-09-01
Vanguard Mid-Cap Growth Fund
#131 of 440 graded active funds · growth · mid segment peer group
The point · specialist footprint
VMGRX puts less of its book behind proven specialists than 70% of graded funds.
Bottom 20%
● Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8 points per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice
You pay 0.33% a year for a B.
The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
Conviction exposure
6%
of the book in specialist-converged names
Late-stage weight
29%
of the book in Crowded or Fading names
Active share
96.7%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book — top names by stage · as of 2026-09-09
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
VMGRX earns a B grade and ranks 131 of 440 funds, with a low 0.33% fee that is one of its clearest strengths. Specialist backing is thin at 6%, and 29% of the portfolio sits in late-stage trades. The early bright spot is LYV, AFRM, and RDDT, where proven specialists are still building, but CPNG, TKO, and WH are all Fading.
→ Watch CPNG, TKO, and WH closely, together they are nearly 7.5% of the fund and specialists are actively leaving all three.
→ The 0.33% fee is low, but the B grade and thin specialist backing argue for checking whether a higher-graded peer justifies any cost difference.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.
The evidence base updates this week.
The specialists — not the whales — are already positioned for what comes next. Stop finding out last.
Create your free accountNo card required · open the feed in 30 seconds